Ken Fisher's CRSP Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 77,960 shares of CRISPR Therapeutics AG (CRSP) worth $4.25 M, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ken Fisher has initiated a new position in CRSP, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's CRISPR Therapeutics (CRSP) Holding Value Over Time
Track share changes against reported price movement
Quarterly CRISPR Therapeutics (CRSP) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +77,960 | New Buy | 77,960 | $54.54 |
Ken Fisher's CRISPR Therapeutics Investment FAQs
Ken Fisher first purchased CRISPR Therapeutics AG (CRSP) in Q2 2026, acquiring 77,960 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held CRISPR Therapeutics AG (CRSP) for 1 quarters since Q2 2026.
Ken Fisher's largest addition to CRISPR Therapeutics AG (CRSP) was in Q2 2026, adding 77,960 shares worth $4.25 M.
According to the latest 13F filing for Q2 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 77,960 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $4.25 M.
As of the Q2 2026 filing, CRISPR Therapeutics AG (CRSP) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in CRISPR Therapeutics AG (CRSP) was 77,960 shares, as reported at the end of Q2 2026.